AMANDA BRODTON: Open Payments
NPI 1336820471 · ATLANTIC CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 27 payments from 3 companies in 2025. Trend: 2023 $34 · 2024 $229 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $274 |
| GENZYME CORPORATION | 6 | $200 |
| Genentech USA, Inc. | 1 | $17 |
Products named: NUCALA, DUPIXENT, Xolair.
Industry payments across NJ — which companies pay providers there.
